Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)

NCT00941109 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: decitabine
DRUG: decitabine
DRUG: decitabine
DRUG: decitabine

Sponsor

Eisai Inc.